COMBINAISONS D'ANTAGONISTES DE PD-1 ET D'AGONISTES DE STING DINUCLÉOTIDIQUES CYCLIQUES POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.

发明人:

CEMERSKI, Saso,CUMMING, Jared, N.,KOPINJA, Johnny, E.,MA, Yanhong,PERERA, Samanthi, A.,TROTTER, Benjamin, Wesley,TSE, Archie Ngai-Chiu

申请号：

EP17885367

公开号：

EP3558358A4

申请日:

2017.12.15

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Therapeutic combinations that comprise at least one antagonist of the Programmed Death 1 receptor (PD-1) and at least one cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway are disclosed herein. Also disclosed is the use of such therapeutic combinations for the treatment of cancers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/